Novo Holdings is expected to acquire 60% of Single Use Support, with the remaining shares being held by Danaher and the company founders.
Related Posts
Health In Tech Announces New Partnerships to Expand Health Insurance Options for Employers in Southern Ohio
Moderna Awarded $176 Million from the Biomedical Advanced Research and Development Authority to Expedite Development of mRNA-Based Influenza Vaccines